Anti-proliferative, anti-migration, and anti-invasion activity of novel hesperidin glycosides in non-small cell lung cancer A549 cells

Natwadee Poomipark , Titaporn Chaisin, Jarunee Kaulpiboon

Abstract


Background and purpose: Several attempts have been made to synthesize and investigate modified flavonoids to improve their potential anticancer efficacy. This study aimed to determine the in vitro anti-viability, anti-migration, and anti-invasive effects of two novel hesperidin glycosides, hesperidin glucoside (HG1) and hesperidin maltoside (HG2), compared to original hesperidin and diosmin.

Experimental approach: Inhibitory effects on normal (MRC5) and cancer (A549) cell viability of hesperidin glycosides were investigated by the trypan blue and MTS assays. A scratch assay determined the suppressive effects on cancer cell migration, and inhibition of cancer cell invasion was investigated through Matrigel™. The selectivity index (SI), a marker of cell toxicity, was also determined for A549 relative to MRC5 cells.

Findings/Results: The cell viability trypan blue and MTS assays showed similar results of the inhibition of A549 cancer cells; HG1 and HG2 had lower IC50 than original hesperidin and diosmin. The SI of HG1 and HG2 was > 2 after 72-h culture. Investigation of cell migration showed that HG1 and HG2 inhibited the ability of gap closure in a time- and dose-dependent manner. The infiltration of the Matrigel™-coated filter by A549 cells was suppressed in the presence of HG1 and HG2. This result implied that HG1 and HG2 could inhibit cancer cell invasion. 

Conclusion and implication: Our results suggest the inhibition of cancer cell migration and invasion in a time- and concentration-related manner with a favorable toxic profile. Moreover, HG1 and HG2 appeared potentially better agents than the original hesperidin for future anticancer development.

 

Highlights

Jarunee Kaulpiboon:PubMed 


Keywords


Anticancer; Anti-invasion; Anti-migration; Anti-proliferation; Hesperidin glycosides.

Full Text:

PDF

References


Ma X, Yu H. Cancer issue: global burden of cancer. Yale J Biol Med. 2006;79(3-4):85-94.PMID: 17940618.

Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer. 2012;12:385,1-90. DOI: 10.1186/1471-2407-12-385.

Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P. Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856(2):189-210. DOI: 10.1016/j.bbcan.2015.08.002.

Devi KP, Rajavel T, Nabavi SF, Setzer WN, Ahmadi A, Mansouri K, et al. Hesperidin: a promising anticancer agent from nature. Ind Crops Prod. 2015;76:582-589. DOI: 10.1016/j.indcrop.2015.07.051.

Sangha R, Price J, Butts CA. Adjuvant therapy in non-small cell lung cancer: current and future directions. Oncologist. 2010;15(8):862-872. DOI: 10.1634/theoncologist.2009-0186.

Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: indexing natural products for their anticancer bioactivity. PloS One. 2017;12(11):e0187925,1-12. DOI: 10.1371/journal.pone.0187925.

Cincin ZB, Unlu M, Kiran B, Bireller ES, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cell Oncol (Dordr). 2015;38(3):195-204. DOI: 10.1007/s13402-015-0222-z.

Ravishankar D, Watson KA, Greco F, Osborn HMI. Novel synthesised flavone derivatives provide significant insight into the structural features required for enhanced anti-proliferative activity. RSC Adv. 2016;6(69):64544-64556. DOI: 10.1039/C6RA11041J.

Chen P, Xu R, Wang J, Wu Z, Yan L, Zhao W, et al. Starch biotransformation into isomaltooligosaccharides using thermostable alpha-glucosidase from Geobacillus stearothermophilus. Peer J. 2018;6:e5086,1-22. DOI: 10.7717/peerj.5086.

Luo Y, Shang P, Li D. Luteolin: a flavonoid that has multiple cardio-protective effects and its molecular mechanisms. Front Pharmacol. 2017;8:692,.DOI: 10.3389/fphar.2017.00692,1-10.

Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G. Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer. 2015;15:682,1-11. DOI: 10.1186/s12885-015-1706-y.

Xia R, Xu G, Huang Y, Sheng X, Xu X, Lu H. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway. Life Sci. 2018;201:111-120. DOI: 10.1016/j.lfs.2018.03.046.

Xia R, Sheng X, Xu X, Yu C. Hesperidin induces apoptosis and G0/G1 arrest in human non-small cell lung cancer A549 cells. Int J Mol Med. 2018;41(1):464-472. DOI: 10.3892/ijmm.2017.3250.

Chaisin T, Kaulpiboon J, Poomipark N. Acceptor specificity of recombinant cyclodextrin glycosyltransferase from Bacillus circulans A11. Sci Tech Asia. 2018;23:86-97. DOI: 10.14456/scitechasia.2018.17.

Kometani T, Terada Y, Nishimura T, Takii H, Okada S. Transglycosylation to hesperidin by cyclodextrin glucanotransferase from an alkalophilic Bacillus species in alkaline pH and properties of hesperidin glycosides. Biosci Biotechnol Biochem. 1994;58(11):1990-1994. DOI: 10.1271/bbb.58.1990.

Kometani T, Nishimura T, Nakae T, Takii H, Okada S. Synthesis of neohesperidin glycosides and naringin glycosides by cyclodextrin glucanotransferase from an alkalophilic Bacillus species. Biosci Biotechnol Biochem. 1996;60(4):645-649. DOI: 10.1271/bbb.60.645.

Poomipark N, Chaisin T, Kaulpiboon J. Synthesis and evaluation of antioxidant and β-glucuronidase inhibitory activity of hesperidin glycosides. Agr Nat Resour. 2020;54(2):165-172. DOI: 10.34044/j.anres.2020.54.2.07.

Chaisin T, Rudeekulthamrong P, Kaulpiboon J. Enzymatic synthesis, structural analysis, and evaluation of antibacterial activity and α-glucosidase inhibition of hesperidin glycosides. Catalysts. 2021;11(5):532,1-17. DOI: 10.3390/catal11050532.

Huwait E, Mobashir M. Potential and therapeutic roles of diosmin in human diseases. Biomedicines. 2022;10(5):1076,1-25. DOI: 10.3390/biomedicines10051076.

Prayong P, Barusrux S, Weerapreeyakul N. Cytotoxic activity screening of some indigenous Thai plants. Fitoterapia. 2008;79(7-8):598-601. DOI: 10.1016/j.fitote.2008.06.007.

Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014(88):51046,1-8. DOI: 10.3791/51046.

Manthey JA, Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem. 2002;50(21):5837-5843. DOI: 10.1021/jf020121d.

Aggarwal V, Tuli HS, Thakral F, Singhal P, Aggarwal D, Srivastava S, et al. Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements. Exp Biol Med (Maywood). 2020;245(5):486-497. DOI: 10.1177/1535370220903671.

van Acker SA, van den Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med. 1996;20(3): 331-342. DOI: 10.1016/0891-5849(95)02047-0.

Murthy KNC, Kim J, Vikram A, Patil BS. Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chem. 2012;132(1):27-34. DOI: 10.1016/j.foodchem.2011.10.014.

Krych-Madej J, Gebicka L. Catalase is inhibited by flavonoids. Int J Biol Macromol. 2013; 58:148-153. DOI: 10.1016/j.ijbiomac.2013.03.070.

Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12(2):457,1-24. DOI: 10.3390/nu12020457.

Simunkova M, Barbierikova Z, Jomova K, Hudecova L, Lauro P, Alwasel SH, Alhazza I, Rhodes CJ, Valko M. Antioxidant vs. prooxidant properties of the flavonoid, kaempferol, in the presence of Cu (II) ions: a ROS-scavenging activity, Fenton reaction and DNA damage study. Int J Mol Sci. 2021;5;22(4):1619. DOI: 10.3390/ijms22041619.

Kongtawelert P, Wudtiwai B, Shwe TH, Pothacharoen P, Phitak T. Inhibitory effect of hesperidin on the expression of programmed death ligand (PD-L1) in breast cancer. Molecules. 2020;25(2):252,1-11. DOI: 10.3390/molecules25020252.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.